- Home
- ATRA vs PGP Comparison
ATRA vs PGP Comparison
Compare ATRA & PGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRA
- PGP
- Stock Information
- Founded
- ATRA 2012
- PGP 2003
- Country
- ATRA United States
- PGP United States
- Employees
- ATRA N/A
- PGP N/A
- Industry
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- PGP Finance Companies
- Sector
- ATRA Health Care
- PGP Finance
- Exchange
- ATRA Nasdaq
- PGP Nasdaq
- Market Cap
- ATRA 97.0M
- PGP 97.1M
- IPO Year
- ATRA 2014
- PGP N/A
- Fundamental
- Price
- ATRA $15.21
- PGP $8.58
- Analyst Decision
- ATRA Strong Buy
- PGP
- Analyst Count
- ATRA 3
- PGP 0
- Target Price
- ATRA $21.00
- PGP N/A
- AVG Volume (30 Days)
- ATRA 54.6K
- PGP 39.8K
- Earning Date
- ATRA 11-06-2025
- PGP 01-01-0001
- Dividend Yield
- ATRA N/A
- PGP 10.84%
- EPS Growth
- ATRA N/A
- PGP N/A
- EPS
- ATRA 0.56
- PGP N/A
- Revenue
- ATRA $188,667,000.00
- PGP N/A
- Revenue This Year
- ATRA N/A
- PGP N/A
- Revenue Next Year
- ATRA N/A
- PGP N/A
- P/E Ratio
- ATRA $27.00
- PGP N/A
- Revenue Growth
- ATRA 202.41
- PGP N/A
- 52 Week Low
- ATRA $5.01
- PGP $5.83
- 52 Week High
- ATRA $18.71
- PGP $7.81
- Technical
- Relative Strength Index (RSI)
- ATRA 55.36
- PGP 55.72
- Support Level
- ATRA $14.14
- PGP $8.13
- Resistance Level
- ATRA $16.15
- PGP $8.54
- Average True Range (ATR)
- ATRA 1.06
- PGP 0.13
- MACD
- ATRA -0.11
- PGP 0.00
- Stochastic Oscillator
- ATRA 44.28
- PGP 78.95
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
About PGP Pimco Global StocksPlus & Income Fund of Beneficial Interest
PIMCO Global Stocksplus & Income Fund is a closed-end management investment company. The objective of the fund is to seek a total return comprised of current income, current gains, and long-term capital appreciation. The fund invests a majority of the fund's net assets in a combination of securities and instruments that provide exposure to stocks and or produce income.